C-type natriuretic peptide and its relation to non-invasive indices of left ventricular function in patients with chronic heart failure

Peptides. 2008 Jan;29(1):79-82. doi: 10.1016/j.peptides.2007.10.022. Epub 2007 Nov 4.

Abstract

C-type natriuretic peptide (CNP) significantly increases in chronic heart failure (CHF) patients as a function of clinical severity. Aim of this study was to evaluate in CHF patients the relationship between circulating CNP concentrations and echo-Doppler conventional indices of left ventricular (LV) function as well as less load independent parameters as dP/dt. LV ejection fraction (EF), left ventricular end-diastolic dimension (LVEDD) and LV dP/dt were evaluated together with plasma CNP levels in 38 patients with CHF and in 63 controls. CNP levels resulted significantly higher in CHF patients than in controls (7.19+/-0.59 pg/ml vs. 2.52+/-0.12 pg/ml, p<0.0001). A significant correlation between dP/dt and CNP levels (r=-0.61, p<0.0001) was observed. A good correlation with EF (r=-0.55, p<0.001) and a less significant relation with LVEDD (r=0.316, p<0.05) were also reported. When patients were divided according to dP/dt values a very significant difference in CNP levels was observed: Group I (<600, n=25) vs. Group II (>600, n=13): 8.46+/-0.69 and 4.75+/-0.75 pg/ml, respectively, p<0.001. This is the first study that reports a correlation between CNP and dP/dt in CHF patients, thus suggesting a possible role on cardiac contractility.

MeSH terms

  • Chronic Disease
  • Echocardiography, Doppler / methods
  • Female
  • Heart Failure / blood*
  • Heart Failure / diagnosis
  • Heart Failure / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Natriuretic Peptide, C-Type / blood*
  • Predictive Value of Tests
  • Reproducibility of Results
  • Severity of Illness Index
  • Ventricular Dysfunction, Left / blood
  • Ventricular Dysfunction, Left / physiopathology*

Substances

  • Natriuretic Peptide, C-Type